King's, Invesco cash in on Proximagen
King's College London and Invesco's leading fund manager Neil Woodford were among the big winners this week as the UK drugs developer Proximagen was snapped up by its US partner in a deal worth up to £356.8m.
Upsher-Smith, a 17 per cent shareholder and commercial partner of Proximagen since 2008, is buying the firm to boost its pipeline and research and development capacity.
The shares jumped 21 per cent to 335p and the acquisition sees King's 3.5 per cent stake valued at a potential £12.5m, while Mr Woodford's Invesco, the biggest shareholder with 26.8 per cent, lands up to £96m.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies